DNKO has joined forces with the Musella Foundation a 501(c)(3) Nonprofit to raise funds for preclinical glioblastoma studies and new clinical trials for brain tumor patients. Our next milestone is to raise $2.27M for preclinical studies and a Phase I in recurrent GBM patients. 

DNKO thrives on resonant collaboration and transparency. Please don't hesitate to contact us regarding any form of inquiry: 

Kate@DNKO.net Co-Founder & CEO

David@DNKO.net Co-Founder & CSO

We're particularly interested in collaborating with people who have interest and/or expertise in: 

• Fundraising/Philanthropy

• Marketing & Communications

• Clinical collaborators using LITT and hyperthermia and ablation technology 

• Preclinical and clinical research for brain cancers and other cancers in general